This inventor holds 1 USPTO granted patent. Top assignees: Chiba University, Fujikura Kasei Co., Ltd., The University of Osaka. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 156 
1 out of 1 
1 out of 3 Years Active: 2026
Title: The Innovations of Hideyuki Kuroda
Introduction
Hideyuki Kuroda is a notable inventor based in Kuki, Japan. He has made significant contributions to the field of biomedical research, particularly in the detection of cerebral infarction risks. His innovative work has garnered attention in both academic and industrial circles.
Latest Patents
Kuroda holds a patent titled "Body Fluid Antibody Biomarker for Highly Sensitive Detection of Risk of Onset of Cerebral Infarction." This patent represents a breakthrough in the early detection of cerebral infarction, which can lead to timely medical interventions and improved patient outcomes. He has 1 patent to his name.
Career Highlights
Throughout his career, Kuroda has worked with prestigious institutions, including The University of Osaka and Fujikura Kasei Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Kuroda has collaborated with notable colleagues such as Go Tomiyoshi and Takaki Hiwasa. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Hideyuki Kuroda's contributions to the field of biomedical research exemplify the importance of innovation in healthcare. His patent for detecting cerebral infarction risk showcases his commitment to improving medical diagnostics and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile